Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Rasko

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Neuromuscular Disorders : NMD|August 22, 2006
Induced dystrophin exon skipping in human muscle explantsG McClorey, A M Fall, H M Moulton, et al.
Experimental Hematology|August 1, 1996
Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewalC G Begley, J E Rasko, D Curtis, et al.
Blood|September 10, 1998
Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factorH P Kiem, R G Andrews, J Morris, et al.
Blood|July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter studyD B Brettler, P M Mannucci, A Gringeri, et al.
Lancet (London, England)|November 9, 1996
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
Blood|May 1, 1997
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Blood|November 1, 1996
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activationC J O'Malley, J E Rasko, R L Basser, et al.
Cancer Research|August 17, 2001
Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCFJ E Rasko, E M Klenova, J Leon, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neuromuscular Disorders : NMD|August 22, 2006
Induced dystrophin exon skipping in human muscle explantsG McClorey, A M Fall, H M Moulton, et al.
Experimental Hematology|August 1, 1996
Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewalC G Begley, J E Rasko, D Curtis, et al.
Blood|September 10, 1998
Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factorH P Kiem, R G Andrews, J Morris, et al.
Blood|July 15, 1992
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter studyD B Brettler, P M Mannucci, A Gringeri, et al.
Lancet (London, England)|November 9, 1996
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
Blood|May 1, 1997
Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancerR L Basser, J E Rasko, K Clarke, et al.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Blood|November 1, 1996
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activationC J O'Malley, J E Rasko, R L Basser, et al.
Cancer Research|August 17, 2001
Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCFJ E Rasko, E M Klenova, J Leon, et al.
Pageof 3